Cargando…
circRNA-SFMBT2 orchestrates ERα activation to drive tamoxifen resistance in breast cancer cells
Dysregulated ERα signaling is responsible for endocrine resistance and eventual relapse in patients with estrogen receptor-positive (ER(+)) breast cancer. Thus, identifying novel ERα regulators is necessary to fully understand the mechanisms of endocrine resistance. Here, we identified circRNA-SFMBT...
Autores principales: | Li, Zheng, Li, Yaming, Han, Dianwen, Wang, Xiaolong, Li, Chen, Chen, Tong, Li, Wenhao, Liang, Yiran, Luo, Dan, Chen, Bing, Wang, Lijuan, Zhao, Wenjing, Yang, Qifeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390580/ https://www.ncbi.nlm.nih.gov/pubmed/37524698 http://dx.doi.org/10.1038/s41419-023-06006-5 |
Ejemplares similares
-
Fatostatin in Combination with Tamoxifen Induces Synergistic Inhibition in ER-Positive Breast Cancer
por: Liu, Ying, et al.
Publicado: (2020) -
CircRNA-CREIT inhibits stress granule assembly and overcomes doxorubicin resistance in TNBC by destabilizing PKR
por: Wang, Xiaolong, et al.
Publicado: (2022) -
The E3 Ligase TRIM4 Facilitates SET Ubiquitin‐Mediated Degradation to Enhance ER‐α Action in Breast Cancer
por: Han, Dianwen, et al.
Publicado: (2022) -
CircEIF3H-IGF2BP2-HuR scaffold complex promotes TNBC progression via stabilizing HSPD1/RBM8A/G3BP1 mRNA
por: Song, Xiaojin, et al.
Publicado: (2022) -
Circ-TRIO promotes TNBC progression by regulating the miR-432-5p/CCDC58 axis
por: Wang, Zekun, et al.
Publicado: (2022)